<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yokoi S</submitter><funding>MEXT | Japan Society for the Promotion of Science</funding><funding>Japan Agency for Medical Research and Development</funding><pagination>8881-8896</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9698725</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>42(47)</volume><pubmed_abstract>Fused in sarcoma (FUS) is a pathogenic RNA-binding protein in amyotrophic lateral sclerosis (ALS). We previously reported that FUS stabilizes Synaptic Ras-GTPase activating protein 1 (&lt;i>Syngap1&lt;/i>) mRNA at its 3' untranslated region (UTR) and maintains spine maturation. To elucidate the pathologic roles of this mechanism in ALS patients, we identified the &lt;i>SYNGAP1&lt;/i> 3'UTR variant rs149438267 in seven (four males and three females) out of 807 ALS patients at the FUS binding site from a multicenter cohort in Japan. Human-induced pluripotent stem cell (hiPSC)-derived motor neurons with the &lt;i>SYNGAP1&lt;/i> variant showed aberrant splicing, increased isoform α1 levels, and decreased isoform γ levels, which caused dendritic spine loss. Moreover, the &lt;i>SYNGAP1&lt;/i> variant excessively recrui</pubmed_abstract><journal>The Journal of neuroscience : the official journal of the Society for Neuroscience</journal><pubmed_title>The &lt;i>SYNGAP1&lt;/i> 3'UTR Variant in ALS Patients Causes Aberrant &lt;i>SYNGAP1&lt;/i> Splicing and Dendritic Spine Loss by Recruiting HNRNPK.</pubmed_title><pmcid>PMC9698725</pmcid><funding_grant_id>JP21ek0109434</funding_grant_id><funding_grant_id>JP20K16489</funding_grant_id><pubmed_authors>Izumi Y</pubmed_authors><pubmed_authors>Kano O</pubmed_authors><pubmed_authors>Nakatochi M</pubmed_authors><pubmed_authors>Ito T</pubmed_authors><pubmed_authors>Okano H</pubmed_authors><pubmed_authors>Morita M</pubmed_authors><pubmed_authors>Sahashi K</pubmed_authors><pubmed_authors>Yokoi S</pubmed_authors><pubmed_authors>Oda M</pubmed_authors><pubmed_authors>Atsuta N</pubmed_authors><pubmed_authors>Okada Y</pubmed_authors><pubmed_authors>Ishigaki S</pubmed_authors><pubmed_authors>Udagawa T</pubmed_authors><pubmed_authors>Sone T</pubmed_authors><pubmed_authors>Sobue G</pubmed_authors><pubmed_authors>Tohnai G</pubmed_authors><pubmed_authors>Nakamura R</pubmed_authors><pubmed_authors>Katsuno M</pubmed_authors><pubmed_authors>Fujioka Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>The &lt;i>SYNGAP1&lt;/i> 3'UTR Variant in ALS Patients Causes Aberrant &lt;i>SYNGAP1&lt;/i> Splicing and Dendritic Spine Loss by Recruiting HNRNPK.</name><description>Fused in sarcoma (FUS) is a pathogenic RNA-binding protein in amyotrophic lateral sclerosis (ALS). We previously reported that FUS stabilizes Synaptic Ras-GTPase activating protein 1 (&lt;i>Syngap1&lt;/i>) mRNA at its 3' untranslated region (UTR) and maintains spine maturation. To elucidate the pathologic roles of this mechanism in ALS patients, we identified the &lt;i>SYNGAP1&lt;/i> 3'UTR variant rs149438267 in seven (four males and three females) out of 807 ALS patients at the FUS binding site from a multicenter cohort in Japan. Human-induced pluripotent stem cell (hiPSC)-derived motor neurons with the &lt;i>SYNGAP1&lt;/i> variant showed aberrant splicing, increased isoform α1 levels, and decreased isoform γ levels, which caused dendritic spine loss. Moreover, the &lt;i>SYNGAP1&lt;/i> variant excessively recrui</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-06-21T03:14:22.706Z</modification><creation>2025-04-19T22:46:09.471Z</creation></dates><accession>S-EPMC9698725</accession><cross_references><pubmed>36261283</pubmed><doi>10.1523/JNEUROSCI.0455-22.2022</doi></cross_references></HashMap>